PTHS Q1 2026 Earnings Pelthos Therapeutics Surprises with NarrowerThanExpected Loss in Q1 2026 Billionaire Stanley Druckenmiller Invests 3387 Million in Caris Life Sciences During Q1 POWL Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds UK Eases Russian Oil Sanctions Amid Rising Fuel Prices and Strait of Hormuz Concerns LMNR Q1 2026 Earnings Loss Misses Estimates by Wide Margin as Seasonal Headwinds Persist US Governments 2 Billion Quantum Computing Initiative Sparks Surge in Related Stocks Minerva Neurosciences Q1 2026 Earnings EPS Misses Street Estimates Stock Gains on Pipeline Optimism